These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 22550309)

  • 1. Immediate hypersensitivity reaction to gadolinium-based MR contrast media.
    Jung JW; Kang HR; Kim MH; Lee W; Min KU; Han MH; Cho SH
    Radiology; 2012 Aug; 264(2):414-22. PubMed ID: 22550309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of immediate gadolinium contrast media reactions.
    Prince MR; Zhang H; Zou Z; Staron RB; Brill PW
    AJR Am J Roentgenol; 2011 Feb; 196(2):W138-43. PubMed ID: 21257854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse allergic reactions to linear ionic gadolinium-based contrast agents: experience with 194, 400 injections.
    Aran S; Shaqdan KW; Abujudeh HH
    Clin Radiol; 2015 May; 70(5):466-75. PubMed ID: 25626627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephrogenic systemic fibrosis: change in incidence following a switch in gadolinium agents and adoption of a gadolinium policy--report from two U.S. universities.
    Altun E; Martin DR; Wertman R; Lugo-Somolinos A; Fuller ER; Semelka RC
    Radiology; 2009 Dec; 253(3):689-96. PubMed ID: 19789233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse reactions to gadolinium contrast media: a review of 36 cases.
    Murphy KJ; Brunberg JA; Cohan RH
    AJR Am J Roentgenol; 1996 Oct; 167(4):847-9. PubMed ID: 8819369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency and severity of acute allergic-like reactions to gadolinium-containing i.v. contrast media in children and adults.
    Dillman JR; Ellis JH; Cohan RH; Strouse PJ; Jan SC
    AJR Am J Roentgenol; 2007 Dec; 189(6):1533-8. PubMed ID: 18029897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence of adverse reactions to gadolinium-based contrast material and management of patients at increased risk: a survey of the American Society of Neuroradiology Fellowship Directors.
    Murphy KP; Szopinski KT; Cohan RH; Mermillod B; Ellis JH
    Acad Radiol; 1999 Nov; 6(11):656-64. PubMed ID: 10894068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventive Effect of Changing Contrast Media in Patients With A Prior Mild Immediate Hypersensitivity Reaction to Gadolinium-Based Contrast Agent.
    Ryoo CH; Choi YH; Cheon JE; Yoon SH; Kang HR; Park SJ; Lee W
    Invest Radiol; 2019 Oct; 54(10):633-637. PubMed ID: 31033674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nephrogenic systemic fibrosis: risk factors and incidence estimation.
    Sadowski EA; Bennett LK; Chan MR; Wentland AL; Garrett AL; Garrett RW; Djamali A
    Radiology; 2007 Apr; 243(1):148-57. PubMed ID: 17267695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of nephrogenic systemic fibrosis: evaluation of gadolinium chelate contrast agents at four American universities.
    Wertman R; Altun E; Martin DR; Mitchell DG; Leyendecker JR; O'Malley RB; Parsons DJ; Fuller ER; Semelka RC
    Radiology; 2008 Sep; 248(3):799-806. PubMed ID: 18632533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute adverse reactions to magnetic resonance contrast media--gadolinium chelates.
    Li A; Wong CS; Wong MK; Lee CM; Au Yeung MC
    Br J Radiol; 2006 May; 79(941):368-71. PubMed ID: 16632615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allergic-like breakthrough reactions to gadolinium contrast agents after corticosteroid and antihistamine premedication.
    Dillman JR; Ellis JH; Cohan RH; Strouse PJ; Jan SC
    AJR Am J Roentgenol; 2008 Jan; 190(1):187-90. PubMed ID: 18094310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of nephrogenic systemic fibrosis after adoption of restrictive gadolinium-based contrast agent guidelines.
    Wang Y; Alkasab TK; Narin O; Nazarian RM; Kaewlai R; Kay J; Abujudeh HH
    Radiology; 2011 Jul; 260(1):105-11. PubMed ID: 21586680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical safety of gadopentetate dimeglumine.
    Nelson KL; Gifford LM; Lauber-Huber C; Gross CA; Lasser TA
    Radiology; 1995 Aug; 196(2):439-43. PubMed ID: 7617858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypersensitivity reactions and contrast medium injection: are they always related?
    Böhm I; Alfke H; Klose KJ
    Eur J Radiol; 2011 Nov; 80(2):368-72. PubMed ID: 21251786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gadolinium-enhanced MR imaging and nephrogenic systemic fibrosis: retrospective study of a renal replacement therapy cohort.
    Collidge TA; Thomson PC; Mark PB; Traynor JP; Jardine AG; Morris ST; Simpson K; Roditi GH
    Radiology; 2007 Oct; 245(1):168-75. PubMed ID: 17704357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of premedication for non-ionic radio-contrast media hypersensitivity reactions in Korea.
    Kim SH; Lee SH; Lee SM; Kang HR; Park HW; Kim SS; Cho SH; Min KU; Kim YY; Chang YS
    Eur J Radiol; 2011 Nov; 80(2):363-7. PubMed ID: 20619990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gadobenate dimeglumine-enhanced MR imaging breast vascular maps: association between invasive cancer and ipsilateral increased vascularity.
    Sardanelli F; Iozzelli A; Fausto A; Carriero A; Kirchin MA
    Radiology; 2005 Jun; 235(3):791-7. PubMed ID: 15845796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of nephrogenic systemic fibrosis in liver transplantation patients.
    Chow DS; Bahrami S; Raman SS; Rotchel S; Sayre JW; Busuttil RW; Lu DS
    AJR Am J Roentgenol; 2011 Sep; 197(3):658-62. PubMed ID: 21862808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gadolinium-based contrast exposure, nephrogenic systemic fibrosis, and gadolinium detection in tissue.
    Wiginton CD; Kelly B; Oto A; Jesse M; Aristimuno P; Ernst R; Chaljub G
    AJR Am J Roentgenol; 2008 Apr; 190(4):1060-8. PubMed ID: 18356456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.